Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Burandt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Der Pathologe|August 27, 2010
[HER2 ASCO guidelines. The answer to everything?]E Burandt, G Sauter
Der Pathologe|February 6, 2014
[Invasive breast cancer: the current WHO classification]A Lebeau, M Kriegsmann, E Burandt, et al.
Breast Cancer Research and Treatment|January 17, 2013
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancerE Burandt, G Jens, F Holst, et al.
Breast Cancer Research and Treatment|December 25, 2009
Gene amplification in ductal carcinoma in situ of the breastL Burkhardt, T J Grob, I Hermann, et al.
Journal of Clinical Pathology|May 29, 2009
HER-2/neu analysis in breast cancer bone metastasesJ Zustin, K Boddin, M C Tsourlakis, et al.
BMC Cancer|December 18, 2015
Partial PTEN deletion is linked to poor prognosis in breast cancerP Lebok, V Kopperschmidt, M Kluth, et al.
Cancer Biology & Therapy|May 12, 2015
8p deletion is strongly linked to poor prognosis in breast cancerP Lebok, A Mittenzwei, M Kluth, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Der Pathologe|August 27, 2010
[HER2 ASCO guidelines. The answer to everything?]E Burandt, G Sauter
Der Pathologe|February 6, 2014
[Invasive breast cancer: the current WHO classification]A Lebeau, M Kriegsmann, E Burandt, et al.
Breast Cancer Research and Treatment|January 17, 2013
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancerE Burandt, G Jens, F Holst, et al.
Breast Cancer Research and Treatment|December 25, 2009
Gene amplification in ductal carcinoma in situ of the breastL Burkhardt, T J Grob, I Hermann, et al.
Journal of Clinical Pathology|May 29, 2009
HER-2/neu analysis in breast cancer bone metastasesJ Zustin, K Boddin, M C Tsourlakis, et al.
BMC Cancer|December 18, 2015
Partial PTEN deletion is linked to poor prognosis in breast cancerP Lebok, V Kopperschmidt, M Kluth, et al.
Cancer Biology & Therapy|May 12, 2015
8p deletion is strongly linked to poor prognosis in breast cancerP Lebok, A Mittenzwei, M Kluth, et al.
Pageof 1